# Critique: finding-1

- Target Side: side_b
- Target Claim IDs: side_b-claim-1
- Attack Type: evidence_gap
- Severity: high

## Claim Under Attack
Given the absence of supporting evidence in the case packet, the feature should be framed as a limited validation MVP rather than a fully committed product investment.

## Evidence Or Reason
The claim cites 'ctx-1' as its evidence reference, but ctx-1 is merely the case packet itself — which states the scenario is 'new feature with weak evidence,' not 'new feature with no evidence.' Side B escalates 'weak' to 'absent' throughout the artifact ('no supporting evidence, no user research, no usage data, and no validation artifacts'), then uses that inflated characterization to justify defaulting entirely to an experiment brief. This is a straw-man reframing: the scenario asks for a PRD that handles weak evidence with discipline, not one that refuses to commit to anything. The resulting artifact is structurally a PRD but functionally an experiment proposal, which means it sidesteps the core task of making a decision-useful product recommendation under uncertainty. A stronger artifact would have specified what weak evidence exists, what weight it can bear, and what constrained feature shape that evidence actually supports — rather than treating all uncertainty as equivalent to zero signal.

